Evidence map›Paper›PMID 31998302›Full record

ArticleFrontiers in immunology2019

Overexpression of CD6 and PD-1 Identifies Dysfunctional CD8

Gospel Enyindah-Asonye, Anthony Nwankwo, Mohammad Arif Rahman, Ruth Hunegnaw, Christopher Hogge, Sabrina Helmold Hait, Eun-Ju Ko, Tanya Hoang, Marjorie Robert-Guroff

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Gospel Enyindah-AsonyeVaccine Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States.
Anthony NwankwoVaccine Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States.
Mohammad Arif RahmanVaccine Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States.
Ruth HunegnawVaccine Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States.
Christopher HoggeVaccine Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States.
Sabrina Helmold HaitVaccine Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States.
Eun-Ju KoVaccine Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States.
Tanya HoangVaccine Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States.
Marjorie Robert-GuroffVaccine Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States.
National Cancer Institute · USNational Institutes of Health · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Effective CD8

Indexed as

Gene ExpressionSimian Immunodeficiency VirusAnimalsAntigens, CDAntigens, Differentiation, T-LymphocyteBiomarkersCD4 Lymphocyte CountCD8-Positive T-LymphocytesCytokinesDisease ProgressionFemaleImmunophenotypingMacaca mulattaMajor Histocompatibility ComplexMaleProgrammed Cell Death 1 ReceptorAntigens, CDAntigens, Differentiation, T-LymphocyteBiomarkersCD6 antigenCytokinesPDCD1 protein, humanProgrammed Cell Death 1 ReceptorCD6PD-1rhesus macaquesimian immunodeficiency virusT-cell exhaustion

Identifiers

PMID31998302
PMCPMC6961594
OpenAlexW3000054634

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.